IDEXX Laboratories, Inc.
IDXX
주식 순위
#556
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing,... IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
주가
$559.14
시가총액
$44.05B
변동 (1일)
-0.22%
변동 (1년)
-12.00%
국가
US
거래 IDEXX Laboratories, Inc. (IDXX)
카테고리
Healthcare
IDEXX Laboratories, Inc. (IDXX)의 영업이익률
October 2026 기준 영업이익률 TTM: 32.03%
IDEXX Laboratories, Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 32.03%입니다. 2024년 말 기준 영업이익률은 28.95%였습니다.
IDEXX Laboratories, Inc.의 영업이익률 기록 (2000 ~ 2026)
매년 말 영업이익률
| 연도 | 영업이익률 | 변화 |
|---|---|---|
| 2026 (TTM) | 32.03% | 1.36% |
| 2025 | 31.60% | 9.15% |
| 2024 | 28.95% | -3.40% |
| 2023 | 29.97% | 12.29% |
| 2022 | 26.69% | -7.93% |
| 2021 | 28.99% | 12.98% |
| 2020 | 25.66% | 11.71% |
| 2019 | 22.97% | 3.47% |
| 2018 | 22.20% | 5.82% |
| 2017 | 20.98% | 6.34% |
| 2016 | 19.73% | 5.40% |
| 2015 | 18.72% | 6.85% |
| 2014 | 17.52% | -9.55% |
| 2013 | 19.37% | -4.58% |
| 2012 | 20.30% | 4.75% |
| 2011 | 19.38% | 4.87% |
| 2010 | 18.48% | 8.32% |
| 2009 | 17.06% | 1.31% |
| 2008 | 16.84% | 14.09% |
| 2007 | 14.76% | -14.73% |
| 2006 | 17.31% | -4.21% |
| 2005 | 18.07% | -8.13% |
| 2004 | 19.67% | 16.46% |
| 2003 | 16.89% | 5.89% |
| 2002 | 15.95% | 8.87% |
| 2001 | 14.65% | 1.10% |
| 2000 | 14.49% | 0.00% |
유사 기업 또는 경쟁사의 영업이익률
| 회사 | 영업이익률 | 영업이익률 차이 | 국가 |
|---|---|---|---|
| 17.97% | -99.44% |
US
|
|
| 20.42% | -99.36% |
US
|
|
| -10.70% | -100.33% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -99.31% |
US
|
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.